|Bid||48.02 x 1200|
|Ask||54.56 x 1200|
|Day's Range||51.40 - 51.40|
|52 Week Range||39.63 - 51.75|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||1.15|
|Expense Ratio (net)||0.69%|
MONTERREY, Mexico , April 8, 2019 /PRNewswire/ -- ALFA, S.A.B. de C.V. (ALFA), announced today that its first quarter 2019 financial results will be released after the Mexican market close on Tuesday, ...
Hedge Funds beat markets in 2018, dodging all worries. These ETFs should be useful for investors looking to replicate those market legends.
Accelerate Announces Initial Suite of Exchange Traded Alternative Funds Featuring Zero Management Fee
To most, it might seem like a perfunctory run-of-the-mill disclosure, but to Maz Jadallah, CEO of AlphaClone, it provides valuable insight. "Most investors can’t conveniently access established hedge funds and the alpha potential from their investment idea," Jadallah told ETF Trends in an email.
SAN FRANCISCO, June 15, 2018 /PRNewswire/ -- After careful consideration, the Board of Trustees of ETF Series Solutions has determined to close and liquidate the AlphaClone International ETF (Cboe BZX: ALFI) ("ALFI"). AlphaClone, Inc. ("AlphaClone") serves as the investment adviser to ALFI, and Vident Investment Advisory, LLC ("Vident") serves as the sub-adviser to ALFI. AlphaClone recommended the closure and liquidation of ALFI after consideration of current market conditions, as well as the fund's prospects for growth, among other factors.